ANNEX IIRejected health claims
| Application — Relevant provisions of Regulation (EC) No 1924/2006 | Nutrient, substance, food or food category | Claim | EFSA opinion reference |
|---|---|---|---|
| Article 14(1)(a) health claim referring to a reduction of a disease risk | Glucosamine hydrocloride | Slowing down/reduce the destruction process of cartilage of the musculoskeletal system and consequently reduce the risk of osteoarthritis. | Q-2009-00412 |
| Article 14(1)(a) health claim referring to a reduction of a disease risk | Isolated soy protein | Protein-rich soybean component has been shown to lower/reduce blood cholesterol; blood cholesterol lowering may reduce the risk of (coronary) heart disease. | Q-2011-00784 |
| Article 14(1)(a) health claim referring to a reduction of a disease risk | Plant sterols in combination with Cholesternorm®mix | Actively lowers cholesterol. | Q-2009-00237 Q-2011-01114 |
| Article 14(1)(a) health claim referring to a reduction of a disease risk | Eicosapentanoic acid (EPA) | EPA has been shown to reduce the AA/EPA ratio in blood. A high AA/EPA level is a risk factor in the development of attention difficulties in children with ADHD-like symptoms. These children are also characterised by less hyperactivity and/or coexisting oppositional behaviour. | Q-2012-00573 |
| Article 14(1)(a) health claim referring to a reduction of a disease risk | Plant stanols (as plant stanol esters) | Consuming 2 g/day plant stanols (as plant stanol esters) as part of a diet low in saturated fat results in a 2-fold greater reduction in LDL-cholesterol than consuming a low saturated fat diet alone. High cholesterol is a risk factor in the development of coronary heart disease. | Q-2012-00915 |